AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2011
Jan 4, 2011
31676_dirs_2011-01-04_c0b0160f-73d0-458d-972c-61405e1a98fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2011-01-03
Reporting Person: DONENBERG PHILIP B (Sr. VP of Finance, CFO & Sec'y)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-03 | Employee Stock Option (right to buy) | $1.66 | A | 270000 | Acquired | 2021-01-02 | Common Stock (270000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40322 | Direct |
Footnotes
F1: This option vests with respect to 67,500 shares on January 3, 2012, January 3, 2013, January 3, 2014 and January 3, 2015.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3